Study comparing safety of two drug regimens for dilatation of eyes before retinopathy of prematurity screening in preterm neonates: A double blinded Randomized Controlled Trial
Not Applicable
- Conditions
- Health Condition 1: P84- Other problems with newborn
- Registration Number
- CTRI/2022/01/039339
- Lead Sponsor
- AIIMS New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Gestational age at birth is less than 34 weeks or birth weight <1500 gm
Exclusion Criteria
1. Major malformation
2. Hemodynamic instability
3. Suspicion of cardiovascular disease
4. Anatomical variations of the anterior segment
5. Consent denied by the parents/ attendants
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method